azilsartan appears to be characterized by a greater potency and an unusual capacity to persistently block AT1 receptors for longer periods of time than most, if not all, competitor ARBs
azilsartan appears to be characterized by a greater potency and an unusual capacity to persistently block AT1 receptors for longer periods of time than most, if not all, competitor ARBspersistently